PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1413759
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1413759
The global Atherectomy and Thrombectomy Devices Market is set to witness substantial growth from 2024 to 2031. The market is anticipated to expand from US$ 3.6 billion in 2026 to US$ 5.8 billion by 2031, according to a comprehensive analysis by Fairfield Market Research, a leading market research firm.
The COVID-19 pandemic had a temporary impact on the market as several cardiovascular procedures and non-essential therapies were postponed. However, as healthcare activities gradually return to normal, the atherectomy and thrombectomy devices market is expected to regain momentum.
The growing preference for minimally invasive surgeries is a significant driver of the market. These procedures offer reduced pain, shorter hospital stays, and fewer complications. Atherectomy, a minimally invasive artery treatment, is in high demand due to its benefits.
Additionally, ongoing research, favorable medical reimbursement scenarios, and robust distribution systems contribute to market growth.
The scarcity of healthcare workers, particularly in rural areas, poses a challenge. The market's potential is hindered by a lack of trained professionals to handle these devices, coupled with stringent regulations.
North America is poised to maintain the largest market share during the forecast period, driven by factors such as enhanced reimbursements for atherectomy systems, a substantial patient population dealing with peripheral and coronary artery diseases, the adoption of atherectomy systems by medical professionals, and a growing number of clinical trials.
The United States is expected to demonstrate a steady Compound Annual Growth Rate (CAGR) during the forecast period. In addition to the factors mentioned earlier, the increased interest of atherectomy device vendors in the region contributes to the heightened demand for these products.
Furthermore, government initiatives aimed at raising awareness and the necessity for improved healthcare infrastructure are propelling the atherectomy and thrombectomy devices market in North America throughout the forecast period.
The global atherectomy and thrombectomy devices market is poised for robust growth, driven by factors such as the increasing prevalence of cardiovascular disorders and advancements in technology.